Clinical trial

INEC Study: Immuno-modulating Enteral Nutrition in Cancer

NCT00333099 · University Hospital, Clermont-Ferrand, Other · Completed

Key facts

NCT number NCT00333099
Title INEC Study: Immuno-modulating Enteral Nutrition in Cancer
Official title Effect of Enteral Immunonutrition During Chemoradiotherapy in Patients With Head and Neck Cancer or Esophageal Cancer
Lead sponsor University Hospital, Clermont-Ferrand, Other
Collaborators Fonds National d'Aménagement et de Développement du territoire (FNADT) European Regional Development Fund Centre Jean Perrin Centre Leon Berard Institut de Cancérologie de la Loire Centre Hospitalier…
Status Completed
Phase Phase 4
Study type Interventional
Conditions Malnutrition, Esophageal Cancer, Head and Neck Cancer
Intervention type Dietary Supplement, Other
Interventions Impact (R) Enteral Nutrition, impact
Enrollment 250
Start date May 1, 2006
Primary completion Sep 1, 2010
Completion Sep 1, 2011
First posted Jun 2, 2006
Last update posted Sep 14, 2012
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies